Basic FGF and Ki-67 proteins useful for immunohistological diagnostic evaluations in malignant solitary fibrous tumor

Pathology International

Volumn 53, Issue 5, 2003, Pages 284-290

  Sun, Yuliang ^a   Naito, Zenya ^a   Ishiwata, Toshiyuki ^a   Maeda, Shotaro ^a   Sugisaki, Yuichi ^a,b   Asano, Goro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

Author keywords

Basic fibroblast growth factor; Ki 67; Solitary fibrous tumor (SFT)

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER LOCALIZATION; CELL ACTIVITY; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EVALUATION; FIBROMATOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LABELING INDEX; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; MITOSIS RATE; PELVIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE; PROTEIN ANALYSIS; PROTEIN FUNCTION; SOFT TISSUE; TISSUE NECROSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038454777     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01474.x     Document Type: Article

References (45)

1. Klemperer P, Rabin C. Primary neoplasms of the pleura. Arch Pathol 1931; 11: 385-412.
2. Dalton WT, Zolliker AS, McCaughey WTE, Jacques J, Kannerstein M. Localized primary tumors of the pleura. An analysis of 40 cases. Cancer 1979; 44: 1465-75.
3. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. Am J Surg Pathol 1989; 13: 640-58.
4. Briselli M, Mark EJ, Dickersin R. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 1981; 47: 2678-89.
5. Okike N, Bernatz PE, Woolner LB. Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg 1978; 75: 363-72.
6. Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations. Am J Surg Pathol 1998; 22: 1501-11.
7. Foster EA, Ackerman LV. Localized mesotheliomas of the pleura: the pathologic evaluation of 18 cases. Am J Clin Pathol 1960; 34: 349-64.
8. Goodlad JR, Fletcher CDM. Solitary fibrous tumor arising at unusual sites: Analysis of a series. Histopathology 1991; 19: 515-22.
9. Segawa D, Yoshizu H, Haga Y et al. Successful operation for solitary fibrous tumor of the epicardium. J Thorac Cardiovasc Surg 1995; 109: 1246-8.
10. Van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum and lung. Am J Surg Pathol 1994; 18: 814-20.
11. Weiss SW, Brooks JS. Soft Tissue Tumors. Baltimore: Williams & Wilkins, 1996.
12. Nielsen GP, O'Connell JX, Dickersin GR, Rosenberg AE. Solitary fibrous tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol 1997; 10: 1028-37.
13. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol 1995; 26: 428-31.
14. Hanau CA, Miettinen M. Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995; 26: 440-49.
15. Mentzel T, Bainbridge TC, Katenkamp D. Solitary fibrous tumor: clinicopathological, immunohistochemical, and ultrastructural analysis of 12 cases arising in soft tissues, nasal cavity and nasopharynx, urinary bladder and prostate. Virchows Arch 1997; 430: 445-53.
16. Renshaw AA. O13 (CD99) in spindle cell tumors. Appl Immunohistochem 1995; 3: 250-56.
17. Moran CA, Buster S, Koss MN. The spectrum of histologic growth patterns in benign and malignant fibrous tumors of the pleura. Sem Diagn Pathol 1992; 9: 169-80.
18. Witkin GB, Rosai J. Solitary fibrous tumor of the mediastinum: A report of 14 cases. Am J Surg Pathol 1989; 13: 547-57.
19. Scharifker D, Kaneko M. Localized fibrous 'mesothelioma' of pleura (submesothelial fibroma): a clinicopathologic study of 18 cases. Cancer 1979; 43: 627-35.
20. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991; 66: 1095-104.
21. Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989; 109: 1-6.
22. Yu ZX, Biro B, Fu YM et al. Localization of basic fibroblast growth factor in bovine endothelial cells: Immunohistochemical and biochemical studies. Exp Cell Res 1993; 204: 247-59.
23. Brem S, Tsanaclis AM, Gately S, Gross JL, Herblin WF. Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 1992; 70: 2673-80.
24. Li X, Maeda S, Hosone M et al. Expression and localization of basic fibroblast growth factor and its mRNA in solitary fibrous tumor. J Nippon Med Sch 2001; 68: 384-92.
25. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
26. Gerdes J, Lemke H, Baisch H, Wicker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-15.
27. Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res 1989; 49: 2999-3006.
28. Du Manoir MS, Guillaud P, Camus E, Seigneurin D, Brugal G. Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment. Cytometry 1991; 12: 455-63.
29. Braun N, Paadopoulos T, Mueller-Hermelink HK. Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cells. Virchows Arch B 1988; 86: 25-33.
30. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992; 25: 31-40.
31. Endl E, Steinbach P, Knuechel R, Hofstaedter F. Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 1997; 29: 233-41.
32. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489-503.
33. Gerdes J. Ki-67 and other proliferation markers useful for immunohistologioal diagnostic and prognostic evaluations in human malignancies. Samin Cancer Biol 1990; 1: 199-206.
34. Hendrickson MR, Kempson RL. Smooth muscle neoplasms. In: Bennington JE, ed. Surgical Pathology of the Uterine Corpus. Philadelphia: W.B. Saunders, 1980, 468-72.
35. Miracco C, de Santi MM, Pacenti L et al. Telomerase activity, Ki-67, cyclin D1 and A expression, and apoptosis in solitary fibrous tumors: additional features of a predictable course? Pathol Res Pract 2001; 197: 475-61.
36. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
37. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7.
38. Klagsbrun M, Vlodavsky I. Biosynthesis and storage of basic fibroblast growth factor (bFGF) by endothelial cells: implication for the mechanism of action of angiogenesis. Prog Clin Biol Res 1988; 266: 55-61.
39. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987; 8: 95-114.
40. Vlodavsky I, Folkman J, Sullivan R et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987; 84: 2292-6.
41. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296-8.
42. Westphal M, Herrmann H-D. Growth factor biology and oncegene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 1989; 25: 681-94.
43. Renko M, Quarto N, Morimoto T, Rifkin DB. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol 1990; 144: 106-14.
44. Gerdes J, Lellé RJ, Pickartz H. Growth fraction in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 1986; 39: 977-60.
45. Ueda T, Aozasa K, Tsujimoto M. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989; 63: 1607-11.